Increased demand for data on the safety and effectiveness of products in real world settings has led to an expansion of peri- and post-approval studies.

At Elite Research Network, we understand the unique challenges associated with late phase studies. These studies typically require a substantially larger number of patients and can run for five or more years. With the majority of our investigators in private practice, we have access to patient populations for the late phase studies we conduct across multiple therapeutic areas. Our patient recruitment departments assist the study teams in order to meet enrolment goals and maximize retention rates, which are critically important due to the length of these studies.